Diagnostics

Psomagen Selected as Key Service Provider, Will Utilize Ultima Genomics’ UG 100™ Sequencer to Accelerate Chan Zuckerberg Initiative’s Billion Cells ProjectPsomagen Selected as Key Service Provider, Will Utilize Ultima Genomics’ UG 100™ Sequencer to Accelerate Chan Zuckerberg Initiative’s Billion Cells Project

Psomagen Selected as Key Service Provider, Will Utilize Ultima Genomics’ UG 100™ Sequencer to Accelerate Chan Zuckerberg Initiative’s Billion Cells Project

ROCKVILLE, Md., May 5, 2025 /PRNewswire/ -- Psomagen Inc., a multiomics service laboratory serving academic, pharma, biotech, and clinical customers,…

1 month ago
ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutionsESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions

ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions

The company will showcase innovations designed to optimize the oncology care workflow and enable improved patient outcomes CHICAGO--(BUSINESS WIRE)--GE HealthCare…

1 month ago
Hologic Announces Financial Results for Second Quarter of Fiscal 2025Hologic Announces Financial Results for Second Quarter of Fiscal 2025

Hologic Announces Financial Results for Second Quarter of Fiscal 2025

– Revenue of $1,005.3 Million Slightly Exceeds Guidance – – Company Reports GAAP Diluted EPS of ($0.08); Non-GAAP Diluted EPS…

1 month ago
CDx Diagnostics to Present WATS3D Progression Data at DDW 2025CDx Diagnostics to Present WATS3D Progression Data at DDW 2025

CDx Diagnostics to Present WATS3D Progression Data at DDW 2025

Highlights Continued Progress in Early Detection and the Progression of Esophageal Disease SUFFERN, N.Y., May 2, 2025 /PRNewswire/ -- CDx…

1 month ago
Seegene’s CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR AutomationSeegene’s CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation

Seegene’s CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation

Seegene previews a concept video of CURECATM at ESCMID Global 2025, ahead of its anticipated debut in JulyWith a fully…

1 month ago
Fueling Breakthroughs: The Melanoma Research Alliance Announces $9.3M Melanoma Research InvestmentFueling Breakthroughs: The Melanoma Research Alliance Announces $9.3M Melanoma Research Investment

Fueling Breakthroughs: The Melanoma Research Alliance Announces $9.3M Melanoma Research Investment

WASHINGTON, May 1, 2025 /PRNewswire/ -- The Melanoma Research Alliance (MRA), the world's leading non-profit funder of melanoma research, announced…

1 month ago
Promex Industries Expands Best-in-Class Capabilities, Installing Laser Depaneling and Advanced SPI Systems on Manufacturing LinePromex Industries Expands Best-in-Class Capabilities, Installing Laser Depaneling and Advanced SPI Systems on Manufacturing Line

Promex Industries Expands Best-in-Class Capabilities, Installing Laser Depaneling and Advanced SPI Systems on Manufacturing Line

New Capabilities Support Higher-Density Assemblies, Flex Substrates, and Emerging Chiplet Architectures with Precision and ScaleSANTA CLARA, Calif., May 01, 2025…

1 month ago
Palisade Bio’s AI-Driven Approach to IBD Heterogeneity and Efficacy Selected for Presentation at the 3rd Annual Precision Medicine in Inflammatory Bowel Disease SummitPalisade Bio’s AI-Driven Approach to IBD Heterogeneity and Efficacy Selected for Presentation at the 3rd Annual Precision Medicine in Inflammatory Bowel Disease Summit

Palisade Bio’s AI-Driven Approach to IBD Heterogeneity and Efficacy Selected for Presentation at the 3rd Annual Precision Medicine in Inflammatory Bowel Disease Summit

Carlsbad, CA, May 01, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a…

1 month ago